Tumor vaccines for breast cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

1. Dendritic Cells in Cancer Immunology and Immunotherapy.Cancers · 2024
   Review
2. Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells.International journal of molecular sciences · 2023
   Review
3. Cancer Vaccines, Treatment of the Future: With Emphasis on HER2-Positive Breast Cancer.International journal of molecular sciences · 2021
   Review
4. Cancer immunotherapy: a promising dawn in cancer research.American journal of blood research · 2020
   Review
5. Assessing the impact of the addition of dendritic cell vaccination to neoadjuvant chemotherapy in breast cancer patients: A model-based characterization approach.British journal of clinical pharmacology · 2019
   Article
6. The Chinese Herbal Mixture Tien-Hsien Liquid Augments the Anticancer Immunity in Tumor Cell-Vaccinated Mice.Integrative cancer therapies · 2017
   Article
7. Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer.Oncology letters · 2017
   Article
8. Immune effect and safety evaluation of vaccine prepared by dendritic cells modified by rAAV-carrying BCSG1 gene.Gene therapy · 2016
   Article
9. Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccine.Oncology letters · 2016
   Article
10. Immunotherapy for the treatment of breast cancer.Current oncology reports · 2015
    Review
11. Recent advances in the development of breast cancer vaccines.Breast cancer (Dove Medical Press) · 2014
    Review
12. Comparison of immunity in mice cured of primary/metastatic growth of EMT6 or 4THM breast cancer by chemotherapy or immunotherapy.PloS one · 2014
    Article
13. Cure of metastatic growth of EMT6 tumor cells in mice following manipulation of CD200:CD200R signaling.Breast cancer research and treatment · 2013
    Article
14. Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy.Oncoimmunology · 2012
    Article
15. Alpha-Type 1 Polarized Dendritic Cells Loaded with Apoptotic Allogeneic Breast Cancer Cells Can Induce Potent Cytotoxic T Lymphocytes against Breast Cancer.Cancer research and treatment · 2011
    Article
16. Cancer-testis antigen, BORIS based vaccine delivered by dendritic cells is extremely effective against a very aggressive and highly metastatic mouse mammary carcinoma.Cellular immunology · 2011
    Article
17. Progress in the development of a therapeutic vaccine for breast cancer.Breast cancer (Dove Medical Press) · 2010
    Review
18. Current status of mucins in the diagnosis and therapy of cancer.BioFactors (Oxford, England)
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author at 1 institution in 1 country.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as